Slingshot members are tracking this event:
DBV Technologies Receives FDA Fast Track Designation for Viaskin Milk for the Treatment of Cow’s Milk Protein Allergy
Do you think this event is important to the companies below? How will it affect their stock price?
|Impact on Stocks
Slingshot Insights Explained
Sep 21, 2016
Don’t see a project related to the catalyst you care about?
Related Keywords Fast Track Status, Viaskin Milk, Viaskin, Cow Milk Protein Allergy, Immunoglobulin E, Viaskin Milk Efficacy And Safety, Eosinophilic Esophagitis